Biblio
Export 72 results:
[ Author] Title Type Year Filters: First Letter Of Title is G [Clear All Filters]
“Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.”, J Alzheimers Dis, vol. 49, no. 2, pp. 571-9, 2016.
, “Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 59-65, 2017.
, “Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein.”, J Alzheimers Dis, vol. 75, no. 1, pp. 45-60, 2020.
, “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
, “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
, “Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 70, no. 2, pp. 399-412, 2019.
, “Glucose Transporters in Brain: In Health and in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1307-1320, 2017.
, “Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice.”, J Alzheimers Dis, vol. 62, no. 2, pp. 571-578, 2018.
, “Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1157-76, 2016.
, “Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1417-1427, 2017.
, “Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
, “Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 3, pp. 971-981, 2018.
, “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.
, “Glucagon-Like Peptide-2 Receptor is Involved in Spatial Cognitive Dysfunction in Rats After Chronic Cerebral Hypoperfusion.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1559-1576, 2018.
, “Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 171-181, 2017.
, “Genetically Determined Serum Uric Acid and Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1259-1265, 2018.
, “Geographical Variation in the Diagnostic Rate and Quality of Dementia Diagnoses.”, J Alzheimers Dis, vol. 69, no. 2, pp. 513-520, 2019.
, “Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1183-1192, 2016.
, “GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 807-819, 2018.
, “Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 81, no. 2, pp. 583-595, 2021.
, “Gut Microbiome is Altered in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1337-1346, 2018.
, “Gamma Entrainment in a Large Retrospective Cohort: Implications for Photic Stimulation Therapy for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1181-1190, 2020.
,